MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with A

Acamprosate

Acamprosate 333mg gastro-resistant tablets

Compatible

Stability notes for Acamprosate 333mg gastro-resistant tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the product Campral EC 333mg tablets (Merck) and Acamprostate 333mg gastro-resistant tablets (Vitatris)

Suppliers (10) of Acamprosate 333mg gastro-resistant tablets
Acamprosate 333mg gastro-resistant tablets (A A H Pharmaceuticals Ltd)
Acamprosate 333mg gastro-resistant tablets (AAH Hillcross)
Acamprosate 333mg gastro-resistant tablets (Alliance Healthcare (Distribution) Ltd)
Acamprosate 333mg gastro-resistant tablets (Medihealth (Northern) Ltd)
Acamprosate 333mg gastro-resistant tablets (Necessity Supplies Ltd)
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc)
Acamprosate 333mg gastro-resistant tablets (Somex Pharma)
Acamprosate 333mg gastro-resistant tablets (Viatris UK Healthcare Ltd)
Campral EC 333mg tablets (Merck Serono Ltd)
Campral EC 333mg tablets (Necessity Supplies Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.